Differences in gray matter volumes of subcortical nuclei between major depressive disorder with and without persistent depressive disorder

被引:1
|
作者
Hung, Ching-, I [1 ,2 ]
Wu, Chen-Te [3 ]
Chao, Yi-Ping [4 ,5 ,6 ,7 ]
机构
[1] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan
[4] Chang Gung Univ, Grad Inst Biomed Engn, Taoyuan, Taiwan
[5] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan
[6] Chang Gung Mem Hosp Linkou, Dept Neurol, Taoyuan, Taiwan
[7] Chang Gung Univ, Grad Inst Biomed Engn, Dept Comp Sci & Informat Engn, 259 Wenhua 1st Rd, Taoyuan 33302, Taiwan
关键词
Atrophy; Chronic depression; Dysthymia; Prognosis; 1ST EPISODE; FOLLOW-UP; PUTAMEN; METAANALYSIS; EDUCATION; SYMPTOMS; ATROPHY;
D O I
10.1016/j.jad.2022.10.021
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: This study aimed to compare the differences in gray matter volumes (GMVs) of subcortical nuclei between major depressive disorder (MDD) patients with and without persistent depressive disorder (PDD) at long-term follow-up. Methods: 114 and 94 subjects with MDD, including 48 and 41 with comorbid PDD, were enrolled to undergo high-resolution T1-weighted imaging at first (FIP) and second (three years later, SIP) investigation points, respectively. FreeSurfer was used to extract the GMVs of seven subcortical nuclei, and Generalized Estimating Equation models were employed to estimate the differences in GMVs of subcortical nuclei between the two subgroups. Results: The PDD subgroup had a significantly greater depressive severity and a higher percentage of patients undergoing pharmacotherapy at the FIP as compared with the non-PDD subgroup. These differences became insignificant at the SIP. The PDD subgroup had a significantly (p < 0.003) smaller GMV in the right putamen at the SIP and in the right nucleus accumbens (NAc) at the FIP and SIP as compared with the non-PDD subgroup. After controlling for clinical variables, PDD was independently associated with smaller GMVs in the right putamen and NAc. Limitations: Imaging was not performed at baseline and pharmacotherapy was not controlled at the FIP and SIP. Conclusions: MDD with PDD was associated with smaller GMVs in the right putamen and NAc as compared with MDD without PDD. Whether the two regions are biomarkers related to a poor prognosis and the chronicity of depression requires further study.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 50 条
  • [31] Differences in brain structural abnormalities between bipolar disorder and major depressive disorder
    Choi, J. E.
    Ha, T. H.
    Kim, J. H.
    Cha, B.
    Ha, K.
    BIPOLAR DISORDERS, 2008, 10 : 72 - 72
  • [32] Are There Meaningful Differences Between Major Depressive Disorder, Dysthymic Disorder, and Their Subthreshold Variants?
    Moore, Michael T.
    Brown, Timothy A.
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2012, 200 (09) : 766 - 772
  • [33] Relationship between epigenetic markers and hypothalamus volumes in major depressive disorder
    Suh, J. S.
    Fiori, L.
    Ali, M.
    Minuzzi, L.
    Harkness, K.
    Turecki, G.
    MacQueen, G.
    Hassel, S.
    Foster, J.
    Lam, R. W.
    Milev, R.
    Soares, C.
    Uher, R.
    Kennedy, S.
    Frey, B.
    BIPOLAR DISORDERS, 2020, 22 : 57 - 57
  • [34] Cortical and subcortical gray matter alterations in first-episode drug-naive adolescents with major depressive disorder
    Kim, Ji Hyun
    Suh, Sang-il
    Lee, Ho-Jun
    Lee, Jong-ha
    Lee, Moon-Soo
    NEUROREPORT, 2019, 30 (17) : 1172 - 1178
  • [35] Voxelwise meta-analysis of gray matter reduction in major depressive disorder
    Du, Ming-Ying
    Wu, Qi-Zhu
    Yue, Qiang
    Li, Jun
    Liao, Yi
    Kuang, Wei-Hong
    Huang, Xiao-Qi
    Chan, Raymond C. K.
    Mechelli, Andrea
    Gong, Qi-Yong
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 36 (01): : 11 - 16
  • [36] Gray matter volume and rapid decision-making in major depressive disorder
    Nakano, Masayuki
    Matsuo, Koji
    Nakashima, Mami
    Matsubara, Toshio
    Harada, Kenichiro
    Egashira, Kazuteru
    Masaki, Hiroaki
    Takahashi, Kanji
    Watanabe, Yoshifumi
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2014, 48 : 51 - 56
  • [37] Insular and Hippocampal Gray Matter Volume Reductions in Patients with Major Depressive Disorder
    Stratmann, Mirjam
    Konrad, Carsten
    Kugel, Harald
    Krug, Axel
    Schoening, Sonja
    Ohrmann, Patricia
    Uhlmann, Christina
    Postert, Christian
    Suslow, Thomas
    Heindel, Walter
    Arolt, Volker
    Kircher, Tilo
    Dannlowski, Udo
    PLOS ONE, 2014, 9 (07):
  • [38] Gray matter volume and corresponding covariance connectivity are biomarkers for major depressive disorder
    Hu, Xiao
    Cheng, Bochao
    Tang, Yuying
    Long, Tong
    Huang, Yan
    Li, Pei
    Song, Yu
    Song, Xiyang
    Li, Kun
    Yin, Yijie
    Chen, Xijian
    BRAIN RESEARCH, 2024, 1837
  • [39] Childhood abuse and cortical gray matter volume in patients with major depressive disorder
    Kim, Soo Young
    An, Seong Joon
    Han, Jong Hee
    Kang, Youbin
    Bae, Eun Bit
    Tae, Woo-Suk
    Ham, Byung-Joo
    Han, Kyu-Man
    PSYCHIATRY RESEARCH, 2023, 319
  • [40] Irritability, Depressed Mood, Inattention and Spatial Working Memory in Children and Adolescents with Major Depressive Disorder With/Without Persistent Depressive Disorder
    Alasdair Vance
    Jo Winther
    Child Psychiatry & Human Development, 2021, 52 : 800 - 807